Medicare Enrolled

Dr. Matthew Conigliari, MD

Neurology · Madison, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
8 SHUNPIKE RD STE 2, Madison, NJ 07940
9738452045
In practice since 2005 (20 years)
NPI: 1417958604 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Conigliari from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Conigliari? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Conigliari

Dr. Matthew Conigliari is a neurology specialist in Madison, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Conigliari performed 1,020 Medicare services across 663 unique beneficiaries.

Between the years covered by Open Payments, Dr. Conigliari received a total of $9,246 from 76 pharmaceutical and/or device companies across 652 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Conigliari is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 36% volume in NJ $9,246 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,020
Medicare services
Top 36% in NJ for neurology
663
Unique beneficiaries
$149
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~51 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
678 $144 $201
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
202 $178 $236
New patient office visit, complex (60-74 min) 76 $177 $253
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
26 $48 $85
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
24 $85 $145
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
14 $102 $130
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,246
Total received (2018-2024)
Avg $1,321/year across 7 years
Top 26% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
76
Companies
652
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,120 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$126 (1.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,424
2023
$1,159
2022
$1,319
2021
$1,438
2020
$1,034
2019
$1,585
2018
$1,288

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$330
PFIZER INC.
$212
Teva Pharmaceuticals USA, Inc.
$199
Novartis Pharmaceuticals Corporation
$169
E.R. Squibb & Sons, L.L.C.
$125
TG Therapeutics, Inc.
$77
Celgene Corporation
$70
EMD Serono, Inc.
$65
Lilly USA, LLC
$49
GE HEALTHCARE
$29
Eisai Inc.
$19
Vanda Pharmaceuticals Inc.
$18
CSL Behring
$18
Lundbeck LLC
$17
Biogen, Inc.
$15
UCB, Inc.
$13
Top 3 companies account for 52.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,145
Teva Pharmaceuticals USA, Inc.
$974
ABBVIE INC.
$765
AbbVie Inc.
$519
Sunovion Pharmaceuticals Inc.
$464
Supernus Pharmaceuticals, Inc.
$398
Amgen Inc.
$387
PFIZER INC.
$305
UCB, Inc.
$300
Biogen, Inc.
$295
EMD Serono, Inc.
$213
Lundbeck LLC
$192
Biohaven Pharmaceutical Holding Company Ltd.
$175
E.R. Squibb & Sons, L.L.C.
$141
Grifols USA, LLC
$126
Eisai Inc.
$122
CSL Behring
$122
Alexion Pharmaceuticals, Inc.
$112
Allergan Inc.
$110
UPSHER-SMITH LABORATORIES LLC
$108
Amneal Pharmaceuticals LLC
$97
Greenwich Biosciences, Inc.
$96
SK Life Science, Inc.
$93
Lilly USA, LLC
$91
Biohaven Pharmaceuticals, Inc.
$84
TG THERAPEUTICS, INC.
$78
GENZYME CORPORATION
$77
TG Therapeutics, Inc.
$77
Janssen Pharmaceuticals, Inc
$73
Acorda Therapeutics, Inc
$73
JAZZ PHARMACEUTICALS INC.
$73
Neurocrine Biosciences, Inc.
$70
Celgene Corporation
$70
Nevro Corp.
$63
Genentech USA, Inc.
$60
LivaNova USA, Inc.
$57
Kyowa Kirin, Inc.
$53
Mallinckrodt Enterprises LLC
$45
W. L. Gore & Associates, Inc.
$45
Mitsubishi Tanabe Pharma America, Inc.
$44
Bausch Health US, LLC
$44
Aprecia Pharmaceuticals, LLC
$43
Jazz Pharmaceuticals Inc.
$43
Neurelis, Inc.
$42
ARBOR PHARMACEUTICALS, INC.
$41
CATALYST PHARMACEUTICALS, INC.
$40
ACADIA Pharmaceuticals Inc
$39
Avion Pharmaceuticals
$34
Boston Scientific Corporation
$33
Life Molecular Imaging Ltd
$33
Vanda Pharmaceuticals Inc.
$30
Avanir Pharmaceuticals, Inc.
$30
Bayer HealthCare Pharmaceuticals Inc.
$29
GE HEALTHCARE
$29
BANNER LIFE SCIENCES, LLC
$28
Impax Laboratories, Inc.
$28
Akcea Therapeutics, Inc.
$27
Mallinckrodt LLC
$26
Abbott Laboratories
$18
Banner Life Sciences, LLC
$16
Octapharma USA, Inc.
$15
Currax Pharmaceuticals LLC
$15
Validus Pharmaceuticals LLC
$14
MITSUBISHI TANABE PHARMA AMERICA, INC.
$14
Egalet US Inc
$14
Medtronic USA, Inc.
$13
Allergan, Inc.
$13
Scilex Pharmaceuticals Inc.
$13
Adamas Pharmaceuticals, Inc.
$12
Sobi, Inc
$12
Alnylam Pharmaceuticals Inc.
$12
Assertio Therapeutics, Inc.
$12
Merz Pharmaceuticals, LLC
$12
Harmony Biosciences LLC
$12
EISAI INC.
$11
Sumitomo Pharma America, Inc.
$9
Top 3 companies account for 31.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · Betaseron · Briviact · CARDIOFORM Septal Occluder · Corlanor · DUOPA · Dhivy · ELIQUIS · EMGALITY · Epidiolex · Equetro · FANAPT · FIRDAPSE · Fycompa · GILENYA · GOCOVRI · GORE CARDIOFORM Septal Occluder · Gamunex-C · Gralise · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LEQEMBI · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NAMZARIC · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · OCREVUS · ONPATTRO · ONZETRA XSAIL · OXTELLAR XR · Ocrevus · Omnia · Ongentys · PANZYGA · PAXLOVID · PONVORY · Ponvory · QULIPTA · RADICAVA · REXULTI · RYTARY · Radicava · Repatha · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · Senza · Soliris · Spritam · TALTZ · TEGSEDI · TOSYMRA · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · Vimpat · Wakix · XYREM · XYWAV · Xeomin · Xyrem · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Madison?
Compare neurologists in the Madison area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
805
Per 100K population
157.7
County median income
$134,929
Nearest hospital
OVERLOOK MEDICAL CENTER
4.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Conigliari is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Conigliari experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Conigliari performed 678 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Conigliari receive payments from pharmaceutical companies?
Yes. Dr. Conigliari received a total of $9,246 from 76 companies across 652 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Conigliari's costs compare to other neurologists in Madison?
Dr. Conigliari's average Medicare payment per service is $149. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Conigliari) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →